Direct Healthcare Group (DHG), a leading manufacturer of pressure care solutions and specialist seating, has announced its completion of the acquisition of GATE Rehab Development AB.

GATE are an experienced manufacturer and supplier of rehabilitation aids to the Swedish healthcare market, including stand tall walkers, transfer platforms and hygiene chairs. GATE and Direct Healthcare Group have a long-standing relationship, with GATE distributing the DHG manufactured Dyna-Form® Static Air HZ for over 2 years.

Direct Healthcare Group, based in South Wales, UK, manufacture innovative, clinically proven, market-leading pressure care management and specialist seating solutions; and have experienced significant growth in the UK, and across their global distributors, since their inception in 2009.

The strategic acquisition provides Direct Healthcare Group with their first expansion into Europe and enables GATE to further increase their portfolio of innovative technologies to the Swedish healthcare market with the addition of award-winning powered hybrid mattresses, an extensive range of pressure reducing and wheelchair cushions, and Specialist Seating solutions.

Johan Gladh, Managing Director at GATE, said: “We are pleased to welcome this next stage of growth for GATE Rehab Development. The acquisition by Direct Healthcare Group will enable us to continue to deliver the high quality of products and service that our customers have come to expect from GATE, but now with the addition of increased efficiencies and an expanded portfolio of powered hybrid mattresses, pressure reducing cushions, and Specialist Seating to enable us to move towards becoming a true solutions provider within Sweden.”

Graham Ewart, CEO at Direct Healthcare Group, said: “The acquisition of GATE represents our first strategic step in delivering our Intelligent Pressure Care Management and Specialist Seating solutions into the Swedish and wider European markets. However, more so, the acquisition further enhances Direct Healthcare Group’s offering and belief in providing solutions that enable the healthcare challenges associated with reduced patient movement to be managed and resolved to support care providers in the delivery of better health outcomes. We are looking forward to continuing to deliver clinically effective solutions that enhance patient recovery to the Swedish market”

Recently, DHG underwent a secondary buyout by European healthcare specialist investor ArchiMed, providing €150million of investment to continue to target strategic acquisitions. The acquisitions will have a particular focus on expanding Direct Healthcare Group’s European presence, whilst simultaneously adding clinically differentiating products that further the company philosophy of advancing movement and health.